https://adisinsight.springer.com/drugsafety/803085160?error=cookies_not_supported&code=7aa5a07c-357e-4a68-b3a6-266eec273a0c
Certolizumab pegol - AdisInsight
A 51-year-old woman developed meningococcal meningoencephalitis while receiving certolizumab pegol for Crohn's disease.The woman had been diagnosed with Crohn's
certolizumab pegoladisinsight
https://www.nice.org.uk/guidance/TA445/history
History | Certolizumab pegol and secukinumab for treating active psoriatic arthritis after...
Evidence-based recommendations on certolizumab pegol (Cimzia) and secukinumab (Cosentyx) for treating active psoriatic arthritis in adults
active psoriatic arthritiscertolizumab pegolhistorysecukinumab
https://adisinsight.springer.com/drugsafety/803925186?error=cookies_not_supported&code=d2975a72-afb5-49e1-b7f2-4941a6b2ff0c
Certolizumab pegol - AdisInsight
A 71-year-old man with a 16-year history of rheumatoid arthritis developed destructive thyroiditis and unmasking of latent amyloid A (AA) amyloidosis following
certolizumab pegoladisinsight
https://experts.arizona.edu/en/publications/health-outcomes-and-cost-effectiveness-of-certolizumab-pegol-in-t/
Health outcomes and cost-effectiveness of certolizumab pegol in the treatment of Crohn's disease -...